ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

计划入组 207 人 · 首次发布于 2020 年 7 月 21 日

Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

计划入组 40 人 · 首次发布于 2025 年 9 月 15 日

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

计划入组 245 人 · 首次发布于 2018 年 2 月 7 日

YAP1 and KRAS Identified as Key Drivers in Soft Tissue Sarcoma Development, Opening New Treatment Avenues

Pembrolizumab Plus Radiotherapy and Surgery Improves DFS in Stage III Soft Tissue Sarcoma

FDA Grants Orphan Drug Designation to Tigilanol Tiglate for Soft Tissue Sarcoma Treatment